The FTO gene test (e.g., rs9939609) is often marketed as a 'fat and appetite gene.' Scientifically, its association with obesity risk and appetite regulation is supported by numerous GWAS, but the effect size is small – carriers of the risk allele have a modest BMI increase of about 0.4 kg/m² per allele. The test can be useful when integrated into a broader analysis (e.g., MyBody-X DNA test) to understand genetic predispositions and tailor nutrition or exercise recommendations. However, evidence that DNA-based diets improve weight loss outcomes is weak. The primary value may be motivational or educational, not diagnostic. Without accompanying lifestyle changes, the test alone has limited practical utility. Consumers should be cautious of exaggerated claims; most effects are population-level and not individually predictive.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-a128d897840c66a7078d2d3b